Pilot study of topical acetyl hexapeptide‐8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy
Authors:
- 12 November 2012
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 20 (3) , 515-518
Abstract
Background and purpose: Injectable botulinum neurotoxin (BoNT) is the principal effective treatment for blepharospasm (BSP). This trial explores the safety and efficacy of topical acetyl hexapeptide‐8 (AH8), a competitive SNAP25 inhibitor, as a potential new therapy in BSP.Methods: Double‐blind, placebo‐controlled, randomized trial of daily topical application of AH8 in 24 patients with BSP. The primary outcome was time to return to baseline Jankovic Blepharospasm Rating Scale (JBRS) after a BoNT injection simultaneously with the initiation of AH8. Patients displaying a strictly regular pattern of response to 3‐monthly injections of BoNT were included.Results: There were no significant adverse events. There was a trend for longer time until return to baseline JBRS after injection in the active group compared to placebo (3.7 months vs. 3.0 months), and for better scores in the active group. One‐third (4/12) of the patients in the active group had a considerable extension of symptom control after BoNT (range: 3.3–7.1 months).Conclusions: Topical AH8 is safe and promising for extending the duration of action of BoNT therapy for BSP.Keywords
This publication has 13 references indexed in Scilit:
- Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptomsJournal of Neurology, 2011
- Eyelid hygiene for blepharitis.2011
- Relationship between various clinical outcome assessments in patients with blepharospasmMovement Disorders, 2009
- The Strange Case of the Botulinum Neurotoxin: Using Chemistry and Biology to Modulate the Most Deadly PoisonAngewandte Chemie International Edition, 2008
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Neurology, 2008
- Safety and efficacy of botulinum toxin type A following long‐term useEuropean Journal of Neurology, 2006
- Internalization and Mechanism of Action of Clostridial Toxins in NeuronsNeuroToxicology, 2005
- A synthetic hexapeptide (Argireline) with antiwrinkle activityInternational Journal of Cosmetic Science, 2002
- The blepharospasm disability scale: An instrument for the assessment of functional health in blepharospasmMovement Disorders, 1995
- Blinking and BlepharospasmJAMA, 1982